In vitro study on the antimicrobial activity of various antibiotics against clinical isolates of Streptococcus pneumoniae from Belgium collected during winter 1998-1999

Acta Clinica Belgica

Volumn 55, Issue 6, 2000, Pages 312-322

  Vanhoof, R ^a   Carpentier, M ^a   Fagnart, O ^a   Garrino, M G ^a   Glupczynski, Y ^a   Gordts, B ^a   Govaerts, D ^a   Magerman, K ^a   Mans, Y ^a   Nyssen, H J ^a   Surmont, I ^a   Schwam, V ^a   Van De Vyvere, M ^a   Van Landuyt, H ^a   Van Nimmen, L ^a   Van Noyen, R ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

Author keywords

Resistance; S. pneumoniae; Surveillance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; CEFACLOR; CEFOTAXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GEMIFLOXACIN; GREPAFLOXACIN; IMIPENEM; LEVOFLOXACIN; MIOKAMYCIN; PENICILLIN G; TETRACYCLINE; TROVAFLOXACIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BELGIUM; DRUG SENSITIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; WINTER;

EID: 0034451274     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.2000.11754318     Document Type: Article

References (31)

1. A resistant pneumococcus
2. The growing threat of antibiotic-resistant Streptococcus pneumoniae
3. Penicillin-resistant Streptococcus pneumoniae in the Netherlands: Results of a 1-year molecular epidemiologic survey
4. β-Lactam resistant Streptococcus pneumoniae: Epidemiology and evolutionary mechanisms
5. Penicillin-resistant pneumococci in the United States
6. In vitro evaluation of the antibiotic susceptibility of Streptococcus pneumoniae: Pneumococci relatively resistant to penicillin in Brussels
7. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993
8. In vitro susceptibility of 176 clinical isolates of Streptococcus pneumoniae to 11 β-lactams, erythromycin ad tetracycline
9. Surveillance of pneumococcal resistance in Belgium during winter 1996-1997
10. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium-update (1994-98)
11. Streptococcus
12. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
13. A 1-year study of antibiotic resistance among paediatric pneumococcal isolates in 1995 from four regions of France
14. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP) study
15. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season
16. Evolution of extended spectrum cephalosporin resistance in the pneumococcus
17. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
18. Emergence in France of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin
19. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander project 1992-1996
20. Comparative in-vitro activities of amoxycillin and penicillin against Streptococcus pneumoniae isolates
21. Primary targets of fluoroquinolones in Streptococcus pneumoniae
22. ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae
23. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae
24. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season
25. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective U.S. study
26. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
27. In-vitro activities of 16 non-β-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae
28. Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms
29. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in Southern Israel